Blaze Bioscience

Blaze Bioscience develops and commercializes products that assist surgeons to treat cancer patients.

Funding reportedLast round: Undisclosed round

BiotechnologySeattle, United States

What company datasets say Blaze Bioscience raised

Funding, as reported

Reported in all$55Min dollars

Rounds6

Last roundUndisclosed round

Last round dateFeb 2019

Investors listed4

SEC Form D$138M sold, 15 filings, last Oct 2024

From Blaze Bioscience's own website: 2 on the team.

AdvisersRegulatory Affairs Key Advisor

Investors who name them

Each firm lists Blaze Bioscience on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Startups like it

Add your raise, your deck and your story, and put Blaze Bioscience in front of investors. Or tell us what we have wrong.